JA_BNJ_Redact.pdf

This is a Justification & Approval (J&A) document for a brand name acquisition from Gallup, Inc. for the FDA's Center for Drug Evaluation and Research (CDER) Office of Compliance Program Management and Analysis Staff.

The acquisition is for fifty (50) Gallup Access workplace surveys and one (1) Gallup Access CliftonStrengths subscription, to be awarded as a firm-fixed-price Purchase Order. This is a follow-on to contract 75F40120P00005 which ran from 11/5/19 to 11/4/24. The subscription includes unlimited web-based employee surveys, five system administrator seats, five survey creator seats, five advanced data user seats, unlimited standard system access, and various reporting capabilities. Key features include ability to conduct unlimited ad-hoc pulse surveys, four annual orientation calls, ability to export reports to multiple formats, and technical help desk support. The CliftonStrengths portion includes one hour of orientation training, five administrator seats, and unlimited access to team reporting and management tools. The procurement is being conducted under FAR 16.505(a)(4) as Gallup is the sole owner of these proprietary services, with no authorized resellers or comparable alternatives available in the market.